Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105764634 | 10576463 | 4 | F | 20120420 | 20160822 | 20141111 | 20160830 | EXP | PHHY2014JP033144 | NOVARTIS | 46.51 | YR | M | Y | 73.00000 | KG | 20160830 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105764634 | 10576463 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 2255 | MG | U | 22334 | 10 | MG | TABLET | QD | |||
| 105764634 | 10576463 | 2 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, QD | 2255 | MG | U | 22334 | 5 | MG | TABLET | QD | |||
| 105764634 | 10576463 | 3 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 2255 | MG | U | 22334 | 10 | MG | TABLET | QD | |||
| 105764634 | 10576463 | 4 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, QD | 2255 | MG | U | 22334 | 5 | MG | TABLET | QD | |||
| 105764634 | 10576463 | 5 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 2255 | MG | U | 22334 | 10 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105764634 | 10576463 | 1 | Pancreatic neuroendocrine tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105764634 | 10576463 | OT |
| 105764634 | 10576463 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105764634 | 10576463 | Cholangitis acute | |
| 105764634 | 10576463 | Diarrhoea | |
| 105764634 | 10576463 | Hepatic function abnormal | |
| 105764634 | 10576463 | Hyperglycaemia | |
| 105764634 | 10576463 | Malignant neoplasm progression | |
| 105764634 | 10576463 | Metastasis | |
| 105764634 | 10576463 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105764634 | 10576463 | 1 | 20120127 | 20120907 | 0 | |
| 105764634 | 10576463 | 2 | 20120907 | 20120907 | 0 | |
| 105764634 | 10576463 | 3 | 20121105 | 20121105 | 0 | |
| 105764634 | 10576463 | 4 | 20130208 | 20131128 | 0 | |
| 105764634 | 10576463 | 5 | 20140120 | 0 |